Satılmış Bilgin
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
Papers in
-
- Chronic Kidney Disease and Diabetes 4
- Gout, Hyperuricemia, Uric Acid 4
- Co-authors
- Burçin Meryem Atak TelTuba Taslamacıoğlu DumanGülali AktaşÖzge KurtkulağıGizem KahveciMehmet Zahid KoçakMehmet Ali KösekliMuhammed Emin Demirkol
- Journals
- The Aging Male (4 papers)Primary care diabetes (1 paper)Revista da Associação Médica Brasileira (3 papers)Postgraduate Medicine (2 papers)Journal of Diabetes & Metabolic Disorders (2 papers)
- Partner nations
- TürkiyePakistanBosnia and Herzegovina
In The Last Decade
Satılmış Bilgin
41 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Nephrology 357
- Endocrinology, Diabetes and Metabolism 276
- Epidemiology 450
- Geriatrics and Gerontology 43
- Oncology 271
Countries citing papers authored by Satılmış Bilgin
This map shows the geographic impact of Satılmış Bilgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satılmış Bilgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satılmış Bilgin more than expected).
Fields of papers citing papers by Satılmış Bilgin
This network shows the impact of papers produced by Satılmış Bilgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satılmış Bilgin. The network helps show where Satılmış Bilgin may publish in the future.
Co-authorship network
The 19 scholars most cited alongside Satılmış Bilgin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 25 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 0 | |
| 12 | A Rare Immune Thrombocytopenia Caused by Brucellosis: A Case Report | 2021 | 1 |
| 13 | 2021 | 15 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 15 | |
| 16 | 2021 | 92 | |
| 17 | 2021 | 74 | |
| 18 | 2020 | 105 | |
| 19 | 2020 | 74 | |
| 20 | 2019 | 9 |
About Satılmış Bilgin
Satılmış Bilgin is a scholar working on Nephrology, Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism, Oncology and Family Practice, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Chronic Kidney Disease and Diabetes (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Diabetes Treatment and Management (4 papers), Gout, Hyperuricemia, Uric Acid (4 papers), COVID-19 Clinical Research Studies (3 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Nephrology (357 citations), Endocrinology, Diabetes and Metabolism (276 citations), Epidemiology (450 citations), Geriatrics and Gerontology (43 citations) and Oncology (271 citations). Satılmış Bilgin has collaborated with scholars based in Türkiye, Pakistan and Bosnia and Herzegovina. Frequent co-authors include Burçin Meryem Atak Tel, Tuba Taslamacıoğlu Duman, Gülali Aktaş, Özge Kurtkulağı, Gizem Kahveci, Mehmet Zahid Koçak, Mehmet Ali Kösekli, Muhammed Emin Demirkol, Buse Balci and Atiqa Khalid. Their work appears in journals such as The Aging Male, Primary care diabetes, Revista da Associação Médica Brasileira, Postgraduate Medicine and Journal of Diabetes & Metabolic Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.